GSK (GSK) announced that the China National Medical Products Administration, CNMPA, has accepted for review the new drug application for the ...
GSK's revenue and EPS exceeded my expectations and those of analysts. Check out the reasons why I am upgrading GSK stock's ...
GSK PLC on Thursday said its monoclonal antibody Nucala, also known as mepolizumab, has been accepted for review in China. The London-based pharmaceutical company said the China Medical Products ...
GSK has garnered FDA approval for its pentavalent meningococcal vaccine Penmenvy, tipped as one of its major launches for ...
3d
The Punch Newspapers on MSNVIDEO: NAFDAC uncovers large consignments of fake Cocodamol, GSK Ampiclox in LagosThe National Agency for Food and Drug Administration and Control has uncovered a massive stockpile of falsified and ...
Shares of GlaxoSmithKline Pharmaceuticals Ltd ended at ₹2,608, up by ₹275.75, or 11.82%, on the BSE. Brokerage firms, ...
UK pharma major GSK late Friday announced that the US Food and Drug Administration (FDA) has approved Penmenvy (meningococcal ...
After years of limping along, the GSK share price has leapt 11% in one month. But one of America's richest investors is ...
GSK Pharma delivered a better-than-expected performance in Q3, largely driven by robust volume growth in the general medicine ...
GlaxoSmithKline Pharmaceuticals reported a significant increase in net profit to Rs 229 crore for the third quarter ending ...
Britain's benchmark index extended declines on Thursday as top healthcare stocks continued to decline on fears of higher U.S.
These latest developments come just a few weeks after DeepSeek's release of a lower-cost AI model rattled markets, as it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results